Multi-event November 2020 FDA Recall Drug by Advanced Nutriceuticals, Llc
This Multi-event Class II drug recall was voluntarily initiated by Advanced Nutriceuticals, Llc on November 30, 2020 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in CA, CO, FL, IN, KY, OH, TX and the recall is currently ongoing.
Reported Recall Events
D-0133-2021 D-0139-2021 D-0130-2021 D-0134-2021 D-0132-2021 D-0140-2021 D-0128-2021 D-0141-2021 D-0131-2021 D-0142-2021 D-0129-2021 D-0135-2021 D-0144-2021 D-0138-2021 D-0143-2021 D-0137-2021 D-0136-2021
Recall Number: D-0133-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
4 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 110220200, 1102202009, Exp 12/09/2020
Lot# 1105202009, Exp 12/20/2020
Lot# 1110202008, Exp 12/10/2020
Recall Number: D-0139-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1110202004 Exp 12/10/2020
Recall Number: D-0130-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1112202006, Exp 12/12/2020
Recall Number: D-0134-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
3 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1029202005,Exp 11/29/2020
Lot# 1102202014, Exp 12/08/2020
Lot# 1112202002, Exp 12/12/2020
Recall Number: D-0132-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
4 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1102202009, Exp 12/08/2020
Lot# 1105202009, Exp 12/20/2020
Lot# 1110202001, Exp 12/15/2020
Lot# 1112202004, Exp 12/12/2020
Recall Number: D-0140-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
3 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1110202005, Exp 12/10/2020
Lot# 1102202015, Exp 12/08/2020
Lot# 1105202009, Exp 12/20/2020
Recall Number: D-0128-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
6 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1029202004, Exp 11/29/2020
Lot# 1102202001, 102202009, Exp 12/08/2020
Lot# 1105202009, Exp 12/20/2020
Lot# 1110202003, Exp 12/10/2020
Lot# 1112202004, Exp 12/12/2020
Recall Number: D-0141-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1030202010, Exp 11/30/2020
Recall Number: D-0131-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
3 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1029202003, Exp 11/29/2020
Lot# 1110202002, Exp 12/10/2020
Lot# 1112202001, Exp 12/12/2020
Recall Number: D-0142-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1029202007, Exp 12/29/20
Recall Number: D-0129-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1112202006, Exp 12/12/2020
Recall Number: D-0135-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1112202008, Exp 12/11/2020
Recall Number: D-0144-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1110202006, exp 12/10/2020
Recall Number: D-0138-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1111202002, Exp 12/11/2020
Recall Number: D-0143-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1105202006, Exp 12/18/2020
Recall Number: D-0137-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
1 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1111202001, Exp 01/11/2021
Recall Number: D-0136-2021
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
11-30-2020
12-23-2020
2 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Advanced Nutriceuticals, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA, CO, FL, IN, KY, OH, TX
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indianapolis, IN
Batch or Lot Expiration Information
Lot# 1113202002, Exp 01/13/2021
Lot# 1102202005, Exp 12/08/2020
